Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Sep 5;367(1601):2402-15.
doi: 10.1098/rstb.2011.0376.

Transcriptional regulation of the 5-HT1A receptor: implications for mental illness

Affiliations
Review

Transcriptional regulation of the 5-HT1A receptor: implications for mental illness

Paul R Albert. Philos Trans R Soc Lond B Biol Sci. .

Abstract

The serotonin-1A (5-HT(1A)) receptor is an abundant post-synaptic 5-HT receptor (heteroreceptor) implicated in regulation of mood, emotion and stress responses and is the major somatodendritic autoreceptor that negatively regulates 5-HT neuronal activity. Based on animal models, an integrated model for opposing roles of pre- and post-synaptic 5-HT(1A) receptors in anxiety and depression phenotypes and response to antidepressants is proposed. Understanding differential transcriptional regulation of pre- versus post-synaptic 5-HT(1A) receptors could provide better tools for their selective regulation. This review examines the transcription factors that regulate brain region-specific basal and stress-induced expression of the 5-HT(1A) receptor gene (Htr1a). A functional polymorphism, rs6295 in the Htr1a promoter region, blocks the function of specific repressors Hes1, Hes5 and Deaf1, resulting in increased 5-HT(1A) autoreceptor expression in animal models and humans. Its association with altered 5-HT(1A) expression, depression, anxiety and antidepressant response are related to genotype frequency in different populations, sample homogeneity, disease outcome measures and severity. Preliminary evidence from gene × environment studies suggests the potential for synergistic interaction of stress-mediated repression of 5-HT(1A) heteroreceptors, and rs6295-induced upregulation of 5-HT(1A) autoreceptors. Targeted therapeutics to inhibit 5-HT(1A) autoreceptor expression and induce 5-HT(1A) heteroreceptor expression may ameliorate treatment of anxiety and major depression.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Model for Htr1a dysregulation in human anxiety and depression. Shown is a model of differential Htr1a regulation in pre-synaptic raphe 5-HT neurons projecting to post-synaptic neurons in target tissues involved in mood and affect, such as prefrontal cortex, hippocampus, amygdala or hypothalamus. Pre-synaptic 5-HT1A autoreceptors (v) negatively regulate 5-HT firing neuronal activity and regulate the release of 5-HT (dots) and activation of post-synaptic 5-HT1A heteroreceptors. In normal subjects, the set point for raphe firing frequency is determined in part by the density of 5-HT1A autoreceptors that is restrained by repression at the rs6295 C(-1019) allele (bar); 5-HT1A heteroreceptors, especially in cortex appear to be increased by enhancer activity at the C(-1019) allele (arrow). In anxiety, the combination of genetic (rs6295 G(-1019) allele) and environmental (life stress) glucocorticoid-mediated repression of the 5-HT1A promoter leads to a stronger decrease in 5-HT1A heteroreceptors in glucocorticoid-sensitive tissues, such as hippocampus and prefrontal cortex, and to a lesser extent the raphe nucleus; anxiety subjects appear to compensate for the de-repression of 5-HT1A autoreceptors in the raphe. In depression, the combination of G(-1019) allele and stress promote reductions in post-synaptic 5-HT1A heteroreceptors; however, pre-synaptic 5-HT1A autoreceptors become upregulated due to the lack of Deaf1 repression at the G(-1019) allele, leading to reduced 5-HT release, and compensatory partial upregulation of 5-HT1A heteroreceptors. In this model, antidepressants act mainly at heteroreceptors or other post-synaptic processes for anti-anxiety actions, while they also act to desensitize pre-synaptic sites to mediate antidepressant actions.

References

    1. Anden N. E., Carlsson A., Haggendal J. 1969. Adrenergic mechanisms. Annu. Rev. Pharmacol. 9, 119–13410.1146/annurev.pa.09.040169.001003 (doi:10.1146/annurev.pa.09.040169.001003) - DOI - DOI - PubMed
    1. Carlsson A. 1975. Dopamine autoreceptors. In Chemical tools in catecholamine research (eds Almgren O., Carlsson A., Engel J.), pp. 219–225 Amsterdam, The Netherlands: North-Holland
    1. Starke K., Gothert M., Kilbinger H. 1989. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev. 69, 864–989 - PubMed
    1. Gothert M. 1982. Modulation of serotonin release in the brain via presynaptic receptors. Trends Pharmacol. Sci. 3, 437–44010.1016/0165-6147(82)91222-6 (doi:10.1016/0165-6147(82)91222-6) - DOI - DOI
    1. Aghajanian G. K. 1982. Regulation of serotonergic neuronal activity: autoreceptors and pacemaker potentials. Adv. Biochem. Psychopharmacol. 34, 173–181 - PubMed

Publication types

MeSH terms